What to do with hepatobiliary cancer

What to do about hepatobiliary cancer?

1. Hepatobiliary cancer, also known as intrahepatic cholangiocarcinoma in clinical practice, is a type of bile duct cancer. The exact cause of the disease is unclear. It is currently believed that it may be related to long-term stimulation by stones or bacterial infection, which leads to destruction of the bile duct mucosal endothelial cells and subsequent hyperplasia and malignant transformation.

2. As the onset of the disease is usually insidious and the disease is usually in the middle or late stages when discovered, the preferred treatment for intrahepatic cholangiocarcinoma is currently radical surgical resection, combined with postoperative chemotherapy and radiotherapy. Generally speaking, as the onset is relatively insidious and the disease is usually in the middle or late stages when discovered, most have a poor prognosis, which means that the treatment effect is poor.

What is the prognosis for bile duct cancer?

Cholangiocarcinoma is highly malignant and generally has a poor prognosis, with a five-year survival rate of approximately 10 to 20%.

That is to say, if you have bile duct cancer, about 20% of the patients can live for five years after surgical treatment. If the bile duct cancer is in a late stage, or even hilar bile duct cancer or lower common bile duct cancer, the surgical trauma is relatively large and it may not be possible to perform radical surgery on the tumor. In this case, the prognosis will be relatively poor.